Bullboard - Stock Discussion Forum Arch Biopartners Inc ACHFF

Primary Symbol: V.ARCH

Technology Scientific & Technical Instruments

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok... see more

Add To Watchlist

Bullboard (TSXV:ARCH)

View:

Post by stocksarefunon Dec 09, 2021 2:12pm

40k sell off there

Wow.

Comment by fourbarrelson Dec 09, 2021 1:47pm

RE:RE:ARCH = Bargain

Exactly. If a buyer waits until the stock is at $30.00 the bid would have to be $40.00 to $50.00 to have any chance at getting accepted.

Discussion

Comment by 2019champson Dec 09, 2021 12:49pm

RE:ARCH = Bargain

The potential is bigger than $30 a share in my opinion. The Company would probably want to do a kidney trial, as the best data in the animal studies was in the kidney! Any positive data in the kidney ...more

115

Discussion

Post by Riverfolkon Dec 09, 2021 12:06pm

Arch Biopartners - A Team That Executes

May 8, 2018 - $.52 Arch Bio Completes Pre-IND Meeting with FDA on LSALT June 19, 2019 - Market Doesn't React Arch Announces Start of Phase I Aug 22, 2019 - Market Doesn't React ...more

165

Post by Riverfolkon Dec 09, 2021 12:02pm

MetaBlok - A Pathway to an unmet 20 billion market

This past week Arch Biopartners released a glimpse of the human data waiting on publication from a third party, that should be expected shortly. This data was further validated by CATCO when they ...more

137

Post by fourbarrelson Dec 09, 2021 11:22am

ARCH = Bargain

How quickly will buyout offers come in when ARCH has a successful CATCO trial? If you're the acquirer you wont want to wait until $30.00 to make an offer. Good news is insiders have controlling ...more

154

Discussion